Abstract:Background: C1q/TNF-related protein (CTRP) 1 was initially identified as a paralog of adiponectin based on the similarity in C1q domain of these two proteins. However, vascular functions of CTRP1 remain largely undetermined. Here, we sought to investigate whether CTRP1 influences the pathogenesis of atherosclerosis. Methods and Results: We analyzed CTRP1 levels in sera of coronary artery disease (CAD) patients (n=451) and non-CAD controls (n=686), in coronary endarterectomy specimens (n=26) and non-atherosclerotic internal mammary arteries (n=32), and in peripheral blood mononuclear cells (PBMCs) from severe CAD patients (n=58) and non-CAD controls (n=25). CTRP1 levels were higher in sera, endarterectomy specimens and PBMCs from CAD patients compared with controls, and were related to CAD severity. Immunohistochemistry of human femoral arteries exhibited VE-cadherin loci-associated increased CTRP1 expression in atherosclerotic plaques. In cultured endothelial cells, CTRP1 stimulation resulted in reduced nitric oxide (NO) bioavailability and promotion of inflammatory reactions (increased production of inflammatory cytokines and induction of adhesion molecules). Intravital microscopy exhibited impaired endothelium-dependent arteriole dilation and enhanced leukocyte-endothelium interactions after injection of recombinant CTRP1, whereas improved arteriole dilation and decreased leukocyte-endothelium interactions were observed in CTRP1 knockout mice. Furthermore, we found that arginase 1 was significantly increased by CTRP1 in a dose-dependent fashion, thereby leading to eNOS-uncoupling and reactive oxygen species generation. Inhibition of arginase activity by synthetic chemicals markedly improved CTRP1-dependent endothelial dysfunction. Finally, intraperitoneal injection of recombinant CTRP1 promoted atherogenesis in apoE-/- mice. In contrast, proatherogenic effects were significantly attenuated in CTRP1-/-/apoE-/- double knockout mice. Conclusions: Our findings have demonstrated that CTRP1 is a pro-atherogenic adipokine, likely by modulating arginase 1 expression and enzyme activity. CTPP1 may represent a crucial therapeutic target in atherosclerosis.

Multi-faceted roles of C1q/TNF-related proteins family in atherosclerosis

C1q Tumor Necrosis Factor–Related Protein 1: A Promising Therapeutic Target for Atherosclerosis

CTRP9 prevents atherosclerosis progression through changing autophagic status of macrophages by activating USP22 mediated-de-ubiquitination on Sirt1 in vitro

C1q/TNF-related Protein 1 Links Macrophage Lipid Metabolism to Inflammation and Atherosclerosis.

CTRP Family in Diseases Associated with Inflammation and Metabolism: Molecular Mechanisms and Clinical Implication.

CTRP1, an Adipokine Causing Endothelial Dysfunction Through Upregulation of Arginase 1, is Associated With the Severity of Coronary Artery Disease in Patients and Promotes Atherogenesis in Mice

Therapeutic Targeting of Pattern Recognition Receptors to Modulate Inflammation in Atherosclerosis

CTRP1: A novel player in cardiovascular and metabolic diseases

C1q/TNF-related Protein-1: an Adipokine Marking and Promoting Atherosclerosis

Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.

Regulatory T Cells As a New Therapeutic Target for Atherosclerosis

Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics

CTRP9: An Anti-Atherosclerotic Factor in ApoE Knockout Mice through Oxidative Stress Inhibition

Research updates of C1q/TNF related proteins(CTRPs)in inflammation-related diseases

Protective Role of C3aR (c3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.

Role of C5a-C5aR axis in the development of atherosclerosis

Pharmacological therapy targeting the immune response in atherosclerosis

CTRP5 Promotes Transcytosis and Oxidative Modification of Low-Density Lipoprotein and the Development of Atherosclerosis

T-Cell Metabolic Reprogramming in Atherosclerosis

C1Q/TNF-related Protein 5 Induces Lipid Uptake and Peroxidation in Endothelium and Promotes Atherogenesis Via Upregulation of 12/15-Lipoxygenase.

Regulatory Roles of Related Long Non-coding RNAs in the Process of Atherosclerosis